Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXeros Tech Regulatory News (XSG)

Share Price Information for Xeros Tech (XSG)

Share Price is delayed by 15 minutes
Get Live Data
1.45    0.05 (3.45%)
Bid:
1.40
Ask:
1.50
Spread: 0.10 (7.143%)
Market Cap: £12.93m
XSG Live PriceLast checked at - London Stock Exchange

Intraday Xeros Tech Share Chart

Trading Update

31 Mar 2022 07:00

RNS Number : 6558G
Xeros Technology Group plc
31 March 2022
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014) which is part of UK law by virtue of the European Union (withdrawal) Act 2018.

 

31st March 2022

 

Xeros Technology Group plc

 

Trading Update

 

Xeros Technology Group plc (AIM: XSG, 'the Group', 'the Company', 'Xeros'), the licensor of proprietary solutions improving the sustainability and economics of the world's clothing and fabrics, today publishes the following update regarding the commercialisation of its platform technologies.

 

In the 27 January 2022 business update the Group referenced positive progress on a number of fronts with the Group's development partners and licensees, notwithstanding the ongoing impact of the Covid pandemic in their various home territories. Since that update, India has come out of its 3rd wave and is operating near normal but China has been experiencing a significant increase in major lockdowns. The Board is continuously reviewing the Group's forward projections in light of these uncertain circumstances. Whilst the Board's view of the overall prospects of the Group remains unchanged, the Board has come to the view that the Group is no longer likely to reach month on month EBITDA profitability and cash breakeven in the first quarter of 2023, as previously guided. The Board now expects this to be reached in 2024.

 

As at 28th February the Group's cash balance was £6.2m. These funds are sufficient to fund the delivery of major growth milestones through the remainder of 2022 and into the first quarter of 2023. The Board is actively evaluating several funding options to secure the remaining investment required.

Since the January business update, commercial discussions with major international organisations for the licensing of the XFiltra filtration technology have progressed in line with expectations and the Company is currently in detailed commercial negotiations which it expects to conclude in the near term. The Group continues to see increasing levels of commercial interest in XFiltra as a result of the combined impetus of legislative developments for microfibre filtration devices in washing machines and growing consumer awareness of the microfibre pollution issue. The Group expects to receive XFiltra revenues from late 2023 onwards.

Also, since the January business update, Xeros' senior management team has travelled to India and Bangladesh to review the progress and growth plans of both IFB and Ramsons. Both license partners stated strong prospects for increasing orders in commercial laundry and denim finishing applications respectively.

Having launched in commercial laundry, IFB and Xeros senior management teams have reviewed and agreed detailed plans for consumer acceptance field trials of their Xeros enabled domestic washing machines, which are due to commence in April. Market entry for these washing machines is planned to be early Q3. IFB continue to show a high degree of commitment towards a successful launch.

In the denim finishing market, supported on the ground by Ramsons and Xeros, Aba continues to work on completing machine cycles for a leading global denim brand as previously communicated. This has extended beyond the February date, as previously advised, pending Xeros' physical support which is now being provided in Dhaka. In addition to this work Ramsons has recently sold Xeros XDrum machines to a further three denim manufacturers in Bangladesh. These manufacturers also produce denim jeans for globally recognised brands. During the course of this year, the Group expects to be able to announce endorsements from major denim brands about the benefits of the Xeros technology in terms of pumice replacement and water and energy savings. Xeros' ambition remains the full elimination of the use of pumice stone from the denim finishing process.

In comparison with the progress made in India, the continuing lockdowns noted above in China have reduced significantly SeaLion's ability to commercialise our commercial laundry technology.

The Group will publish 2021 financial results at a later date and, as usual, this date will be communicated in advance.

 

Mark Nichols, Chief Executive of Xeros, said:

 

 

"Since our update in January, with the exception of China, the levels of activity by our existing partners have continued to be strong as has our engagement with prospective licensees. Our expectations are that multiple agreements will be signed this year with some fairly near term. This is against a background of increasing levels of interest from global brands in our ability to help them meet their major global environmental imperatives."

 

 

Enquiries:

Xeros Technology Group plc

Mark Nichols, Chief Executive Officer

Paul Denney, Chief Financial Officer

Tel: 0114 321 6328

 

finnCap Limited (Nominated Adviser and Broker)

Julian Blunt/Teddy Whiley, Corporate Finance

Andrew Burdis/Sunila de Silva, ECM

Tel: 020 7220 0570

Notes to Editors

 

With close to 40 patent families, Xeros' revolutionary platform technologies, XTend™ and XFiltra™ set new standards for performance and sustainability across our clothing's lifecycle. By reducing the consumption of valuable natural resources and preventing microfibre and microplastic pollution, Xeros greatly reduces the impact of our clothes on the planet.

Backed by science, we set new standards for significantly reduced water consumption, lower carbon and effluent emissions, and improved garment care/life at the manufacturing stage and throughout laundry processes, in industry, and in the home. Xeros' technologies deliver a unique combination of unbeatable sustainability outcomes, improving performance whilst reducing costs. 

The manufacture of clothes and their subsequent care consumes vast amounts of our finite, valuable resources. Xeros licenses new technologies to enable us all to consume less, helping to protect the world for our future. 

For more information, please visit - http://www.xerostech.com/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKKBQPBKDNNN
Date   Source Headline
28th Apr 20267:00 amRNSFull Year Results 2025
21st Apr 20267:00 amRNSNotice of Results and Online Presentation
5th Mar 20267:00 amRNSPurchase Order ahead of European Launch of XF3
11th Feb 202610:39 amRNSHolding(s) in Company
2nd Feb 20267:00 amRNSBoard Change
27th Jan 20267:00 amRNSTrading Update
7th Jan 20262:52 pmRNSTR-1 First Equity
2nd Jan 202611:46 amRNSBlock listing Interim Review
11th Dec 20251:06 pmRNSTR-1 Entrepreneurs Fund
2nd Dec 20254:48 pmRNSTR-1 Lombard Odier
2nd Dec 20252:26 pmRNSTR-1 Dowgate
2nd Dec 202511:10 amRNSTR-1 Maven
28th Nov 202511:02 amRNSResults of General Meeting and Director Dealings
27th Nov 202512:28 pmRNSResult of Follow-on Subscription and TVR
26th Nov 20254:44 pmRNSTR-1 Spreadex
11th Nov 20251:14 pmRNSResult of Retail Offer
7th Nov 202510:15 amRNSResult of Fundraising
7th Nov 20257:00 amRNSRetail Offer
6th Nov 20256:32 pmRNSProposed Fundraise
24th Oct 20253:07 pmRNSBlock listing Interim Review
14th Oct 20255:11 pmRNSTR-1 Maven
10th Oct 20255:20 pmRNSTR-1 Dowgate
9th Oct 20252:05 pmRNSTR-1 Spreadex
9th Oct 202511:04 amRNSTR-1 First Equity
8th Oct 20257:00 amRNSBreakthrough Launch Agreement
1st Oct 20252:08 pmRNS-RInterim Results 2025 Online Presentation
30th Sep 20257:00 amRNSInterim Results 2025
15th Sep 20256:07 pmRNSTR-1 Dowgate
12th Sep 20251:03 pmRNSTR-1 Dowgate
5th Aug 202512:13 pmRNSTR-1 First Equity
7th Jul 20252:33 pmRNSTR-1 Spreadex
19th Jun 20251:46 pmRNSResult of AGM
5th Jun 202510:11 amRNSCorrection - Application for Block Listing
4th Jun 202510:00 amRNSApplication for Block Listing
29th May 20252:43 pmRNSTR-1 Spreadex
28th May 20253:32 pmRNSTR-1 First Equity
28th May 20252:31 pmRNSTR-1 Spreadex
27th May 20252:37 pmRNSNotice of AGM and Posting of Annual Report
20th May 20257:00 amRNSFull Year Results 2024 and Trading Update
9th May 202511:08 amRNSTR-1 Spreadex
7th May 20257:00 amRNSNotice of Results and Online Presentation
6th May 202510:10 amRNSTR-1 Maven Capital
2nd May 20254:00 pmRNSTR-1 Spreadex
1st May 20254:35 pmRNSTR-1 - First Equity
31st Mar 20257:00 amRNSGrant of Options
7th Mar 202512:56 pmRNSTR-1 Spreadex
17th Feb 20252:18 pmRNSTR-1 Spreadex
17th Feb 202511:07 amRNSTR-1 First Equity
13th Feb 202512:05 pmRNSTR-1 Spreadex
13th Feb 202510:21 amRNSTR-1 First Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.